Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Petróleo Brasileiro SA (PBR) Price & Performance

Adaptive Biotechnologies CorpTrade
Petróleo Brasileiro SATrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Petróleo Brasileiro SA — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Petróleo Brasileiro SA trades at $17.94 (market cap $112.19B). The key difference: Petróleo Brasileiro SA is far larger — about 27.8× Adaptive Biotechnologies Corp's market cap, and Petróleo Brasileiro SA pays a 9.42% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTPBR
Market Cap
$4.04B$112.19B
Sector
HealthTechnology
52-Week High
$25.45$22.03
52-Week Low
$12.30$11.54
Enterprise Value
$4.10B$172.61B
Dividend Yield
9.42%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Petróleo Brasileiro SA

Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.

Read more on PBR